LD 1325
pg. 11
Page 10 of 12 PUBLIC Law Chapter 401 Page 12 of 12
Download Chapter Text
LR 1609
Item 1

 
Sec. C-6. 22 MRSA §3174-G, sub-§1-C, as enacted by PL 2001, c. 650,
§3, is amended to read:

 
1-C. Prescription drug waiver program. Except as provided in
paragraph G, the department shall apply to the federal Centers
for Medicare and Medicaid Services for a waiver or amend a
pending or current waiver under the Medicaid program authorizing
the department to use federal matching dollars to enhance the
prescription drug benefits available to persons who qualify for
the elderly low-cost drug program established under section 254
254-D. The program created pursuant to the waiver is the
prescription drug waiver program, referred to in this subsection
as the "program."

 
A. As funds permit, the department has the authority to
establish income eligibility levels for the program up to
and including 200% of the federal nonfarm income official
poverty level, except that for individuals in households
that spend at least 40% of income on unreimbursed direct
medical expenses for prescription medications, the income
eligibility level is increased by 25%.

 
B. To the extent reasonably achievable under the federal
waiver process, the program must include the full range of
prescription drugs provided under the Medicaid program on
the effective date of this subsection and must limit
copayments and cost sharing for participants. If cost
sharing above the nominal cost sharing for the Medicaid
program is determined to be necessary, the department may
use a sliding scale to minimize the financial burden on
lower-income participants.

 
C. Coverage under the program may not be less beneficial to
persons who meet the qualifications of former section 254
than the coverage available under that section on September
30, 2001.

 
D. In determining enrollee benefits under the program, to
the extent possible, the department shall give equitable
treatment to coverage of prescription medications for
cancer, Alzheimer's disease and behavioral health.

 
E. The department is authorized to provide funding for the
program by using funds appropriated or allocated to provide
prescription drugs under sections 254 254-D and 258.

 
Sec. C-7. 24-A MRSA §5002-B, sub-§2-A, as enacted by PL 2001, c. 410,
Pt. B, §7, is amended to read:


Page 10 of 12 Top of Page Page 12 of 12
Related Pages
  Search Bill Text Legislative Information
Bill Directory Search
Bill
Status
Session Information
119th Legislature Bills Maine Legislature

Office of Legislative Information
100 State House Station
Augusta, ME 04333
voice: (207) 287-1692
fax: (207) 287-1580
tty: (207) 287-6826
Word Viewer for Windows Disclaimer